about
Jean-Martin Charcot: the father of neurologyEfficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptomsInduced Stem Cells as a Novel Multiple Sclerosis TherapyThe role of the cerebellum in multiple sclerosis.Characteristics of multiple sclerosis patient stance control disorders, measured by means of posturography and related to brainstem lesions.Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia.Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.Morning glory syndrome associated with multiple sclerosisBiomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary coughMultiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple SclerosisAssociation between the ACCN1 gene and multiple sclerosis in Central East Sardinia.Practice patterns of US neurologists in patients with CIS, RRMS, or RIS: A consensus studyInvestigation of relationship between social capital and quality of life in multiple sclerosis patients.Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.Asymmetrical hip bone density in multiple sclerosis.A systematic review of pharmacological pain management in multiple sclerosis.Clinical course of progressive multiple sclerosis in Brazilian patients.Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signatures.Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study.T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.Neuromyelitis optica immunoglobulin G in Chinese patients detected by immunofluorescence assay on a monkey brain substrate.Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study.Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus.Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis.Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.Correlation between Magnetic Resonance Imaging Findings and Pathological Observations in Tumefactive Multiple Sclerosis.Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel.Effect of pulsed magnetic field therapy on the level of fatigue in patients with multiple sclerosis--a randomized controlled trial.A randomized controlled trial of a health promotion education programme for people with multiple sclerosis.Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
P2860
Q24631743-557A1D1B-D4F7-446B-BDF1-A14FF3D065E0Q24800891-1493484F-275C-4CEF-8370-5CDE4DF6411FQ28081780-7D141E72-DB9B-415F-9198-ADE7B528E048Q30884001-91767DF7-EB74-4087-AEDC-0E20F09863C9Q31021462-E2E3A865-30AF-4332-A210-553355F0E8DAQ33490625-BD41EAA2-713D-46C5-BDB2-9F9624E3B863Q33765725-5E7A9EF7-006B-42E6-9632-45EF0A15BEB0Q33992633-0E10FB02-0E24-4B3C-A73D-57C5A132AA6DQ34559003-BF697CB4-81AF-4E28-B188-06D13AC73489Q35026718-CBEE82AE-3338-4926-A77E-EFC8A0449007Q35062545-D5990F89-656E-405C-8BD8-C3062D737E2BQ35794340-2BFEF0C1-13E1-45E4-A98F-F5DAB57980AAQ35794487-09B23F62-761E-4E48-8782-D23C54DD7E59Q36731490-8444D55A-582B-4566-8B4D-6BE67F0E6305Q36780532-EF2057BC-B1B2-4B51-8954-F3AFC9720CCFQ36818197-05E61753-105A-475A-96BD-6DE604B9409AQ37442014-85E7FF59-091D-40B9-86B3-31DEEA5020E5Q38148499-C331769C-8B19-45AC-A34B-79A232AE195CQ39554847-75D2AFB7-C5E4-42B3-946A-C9A3CD5C14F4Q39801655-95CF923C-D998-4F72-B92D-5213023FCC8CQ40017560-5E0893CD-9DA6-4D4D-BF0D-71AC6E8E48CBQ42285706-C8B84B67-C854-478A-8171-611602D3BF0EQ44019141-BCA90345-6310-4B82-8D7B-7917F919610EQ45231803-E64766DF-F5E0-46AF-A78B-5F0340B1A4A8Q47103678-85B4657A-DDE2-4BCD-8160-58F2884DADB6Q48107749-39FBA420-C986-4378-993A-C8DB15690C1EQ48247708-2915F4C4-01CB-4B06-A5E4-4D3606D6399FQ48543545-8DA9C959-3394-49D8-B8B5-4DB2C24D325CQ48617867-7BA914F3-F810-4FF3-B30B-0F448E52CCF9Q48962492-C30CD883-1CCE-4A96-A5E4-5FAF7870F839Q50547789-C0344F05-7F2D-409F-9672-51F6255AADC0Q51184200-4D99B969-5B27-4A5B-8297-F3AA28A5CB00Q51434259-4E858E6B-9D88-4BBE-90D0-19EFBA3EDE96Q51912182-963B50CA-5913-4F61-96CE-00FF379EF355Q53076494-2E5EA29F-A746-4251-A392-8F040F83C5C1
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Diagnostic criteria for multiple sclerosis.
@ast
Diagnostic criteria for multiple sclerosis.
@en
type
label
Diagnostic criteria for multiple sclerosis.
@ast
Diagnostic criteria for multiple sclerosis.
@en
prefLabel
Diagnostic criteria for multiple sclerosis.
@ast
Diagnostic criteria for multiple sclerosis.
@en
P1476
Diagnostic criteria for multiple sclerosis.
@en
P2093
P356
10.1016/S0303-8467(00)00125-6
P577
2001-04-01T00:00:00Z